|
nasdaq:agen
|
2080230
|
Apr 14th, 2024 12:00AM
|
Agenus
|
35K
|
295.00
|
Open
|
|
Apr 13th, 2024 10:31PM
|
Apr 13th, 2024 10:31PM
|
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA.
For more information, visit www.agenusbio.com or follow us at @agenus_bio.
Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/
|
Open
|
Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing
|
Open
|
3 Forbes Road
|
Lexington
|
Massachusetts
|
US
|
02421
|
|
Agenus
|
|
Health Care Equipment & Services
|
|
nasdaq:agen
|
2080230
|
Apr 13th, 2024 12:00AM
|
Agenus
|
35K
|
295.00
|
Open
|
|
Apr 12th, 2024 10:21PM
|
Apr 13th, 2024 10:58AM
|
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA.
For more information, visit www.agenusbio.com or follow us at @agenus_bio.
Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/
|
Open
|
Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing
|
Open
|
3 Forbes Road
|
Lexington
|
Massachusetts
|
US
|
02421
|
|
Agenus
|
|
Health Care Equipment & Services
|
|
nasdaq:agen
|
2080230
|
Apr 12th, 2024 12:00AM
|
Agenus
|
34K
|
294.00
|
Open
|
|
Apr 11th, 2024 10:24PM
|
Apr 12th, 2024 07:53AM
|
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA.
For more information, visit www.agenusbio.com or follow us at @agenus_bio.
Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/
|
Open
|
Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing
|
Open
|
3 Forbes Road
|
Lexington
|
Massachusetts
|
US
|
02421
|
|
Agenus
|
|
Health Care Equipment & Services
|
|
nasdaq:agen
|
2080230
|
Apr 11th, 2024 12:00AM
|
Agenus
|
34K
|
297.00
|
Open
|
|
Apr 10th, 2024 10:43PM
|
Apr 11th, 2024 10:37AM
|
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA.
For more information, visit www.agenusbio.com or follow us at @agenus_bio.
Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/
|
Open
|
Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing
|
Open
|
3 Forbes Road
|
Lexington
|
Massachusetts
|
US
|
02421
|
|
Agenus
|
|
Health Care Equipment & Services
|
|
nasdaq:agen
|
2080230
|
Apr 10th, 2024 12:00AM
|
Agenus
|
34K
|
297.00
|
Open
|
|
Apr 9th, 2024 10:28PM
|
Apr 10th, 2024 04:46PM
|
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA.
For more information, visit www.agenusbio.com or follow us at @agenus_bio.
Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/
|
Open
|
Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing
|
Open
|
3 Forbes Road
|
Lexington
|
Massachusetts
|
US
|
02421
|
|
Agenus
|
|
Health Care Equipment & Services
|
|
nasdaq:agen
|
2080230
|
Apr 9th, 2024 12:00AM
|
Agenus
|
34K
|
297.00
|
Open
|
|
Apr 8th, 2024 10:38PM
|
Apr 9th, 2024 09:27AM
|
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA.
For more information, visit www.agenusbio.com or follow us at @agenus_bio.
Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/
|
Open
|
Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing
|
Open
|
3 Forbes Road
|
Lexington
|
Massachusetts
|
US
|
02421
|
|
Agenus
|
|
Health Care Equipment & Services
|
|
nasdaq:agen
|
2080230
|
Apr 8th, 2024 12:00AM
|
Agenus
|
34K
|
297.00
|
Open
|
|
Apr 7th, 2024 10:48PM
|
Apr 8th, 2024 06:26PM
|
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA.
For more information, visit www.agenusbio.com or follow us at @agenus_bio.
Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/
|
Open
|
Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing
|
Open
|
3 Forbes Road
|
Lexington
|
Massachusetts
|
US
|
02421
|
|
Agenus
|
|
Health Care Equipment & Services
|
|
nasdaq:agen
|
2080230
|
Apr 7th, 2024 12:00AM
|
Agenus
|
34K
|
300.00
|
Open
|
|
Apr 6th, 2024 10:37PM
|
Apr 6th, 2024 10:37PM
|
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA.
For more information, visit www.agenusbio.com or follow us at @agenus_bio.
Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/
|
Open
|
Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing
|
Open
|
3 Forbes Road
|
Lexington
|
Massachusetts
|
US
|
02421
|
|
Agenus
|
|
Health Care Equipment & Services
|
|
nasdaq:agen
|
2080230
|
Apr 6th, 2024 12:00AM
|
Agenus
|
34K
|
300.00
|
Open
|
|
Apr 5th, 2024 10:37PM
|
Apr 5th, 2024 10:37PM
|
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA.
For more information, visit www.agenusbio.com or follow us at @agenus_bio.
Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/
|
Open
|
Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing
|
Open
|
3 Forbes Road
|
Lexington
|
Massachusetts
|
US
|
02421
|
|
Agenus
|
|
Health Care Equipment & Services
|
|
nasdaq:agen
|
2080230
|
Apr 5th, 2024 12:00AM
|
Agenus
|
34K
|
300.00
|
Open
|
|
Apr 4th, 2024 10:42PM
|
Apr 4th, 2024 10:42PM
|
Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA.
For more information, visit www.agenusbio.com or follow us at @agenus_bio.
Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/
|
Open
|
Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing
|
Open
|
3 Forbes Road
|
Lexington
|
Massachusetts
|
US
|
02421
|
|
Agenus
|
|
Health Care Equipment & Services
|